Jan 9, 2020
A new report on rheumatoid arthritis treatments published by a controversial cost appraiser is facing strong criticism from patient advocates, who say it minimizes the autoimmune disease as simply “morning stiffness” and “joint swelling”. The Institute for Clinical...
Jan 8, 2020
For many patients living with type 2 diabetes, daily injections are a substantial barrier to accessing current treatments. “I literally break down every time I have my bloods done,” one diabetes patient shares of her experience. Another adds, “I have the worst needle...
Oct 19, 2019
Patients Rising Now is welcomes the opportunity to provide recommendations and comments about the pros and cons of ICER’s August 21st document outlining proposed changes to its Value Assessment Framework’s processes and methodology. As advocates for patients with...
Oct 19, 2019
Institute for Patient Access & Affordability (IPAA) is a new program division of Patients Rising with the mission to provide patient-powered pathways to help both public and private payers as they make critical coverage decisions for patients with rare and chronic...
Oct 13, 2019
Patients living with sickle cell disease could run into more insurance barriers as a result of a pending report on two potentially groundbreaking SCD treatments. The Institute for Clinical and Economic Review, which receives support from insurance companies, has begun...
